Image

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

Recruiting
12-18 years
All
Phase N/A

Powered by AI

Overview

The objective of this project is to examine the differential therapeutic effect of intermittent theta burst stimulation (iTBS; a type of repetitive transcranial magnetic stimulation) to the left DLPFC versus right PreSMA in modulating working memory (WM) versus inhibitory control (IC) deficits. Fifty adolescents (12-18 years old) with parent-reported WM and IC deficits and diagnosed ADHD will be randomized to DLPFC or PreSMA targeted 3x-daily iTBS for a total of ten days (30 total sessions).

Eligibility

Inclusion Criteria

  1. Age 12-18 years
  2. English fluency of participant and parent and able to provide informed consent/assent
  3. Clinical diagnosis of ADHD and confirmation of diagnostic criteria on the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders, Child and Adolescent Version (DIAMOND-KID)
  4. Parent rating on The Behavior Rating Inventory of Executive Function-Second Edition (BRIEF-2), Parent Form: Working Memory scale T-Score \> 60 AND Inhibition scale T-Score \> 60
  5. IQ \> 70

Exclusion Criteria

Participants will be screened to exclude individuals with neurological or medical conditions that might confound the results, as well as to exclude participants in whom MRI or TMS might result in increased risk of side effects or complications. Common contraindications include metallic hardware in the body, cardiac pacemaker, patients with an implanted medication pumps or an intracardiac line, or prescription of medications known to lower seizure threshold. These account for most of the exclusion criteria listed below:

  1. Intracranial pathology from a known genetic disorder (e.g., NF1, tuberous sclerosis) or from acquired neurologic disease (e.g. stroke, tumor), cerebral palsy, history of severe head injury, or significant dysmorphology
  2. History of fainting spells of unknown or undetermined etiology that might constitute seizures
  3. History of seizures, diagnosis of epilepsy, or immediate (1st degree relative) family history epilepsy
  4. Any progressive (e.g., neurodegenerative) neurological disorder
  5. Chronic (particularly) uncontrolled medical conditions that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.)
  6. Contraindicated metal implants in the head, brain or spinal cord (excluding dental implants or fillings)
  7. Non-removable makeup or piercings
  8. Pacemaker, implanted medication pump, or ventriculo-peritoneal shunt
  9. Vagal nerve stimulator, deep brain stimulator, or transcutaneous electrical nerve stimulation unit
  10. Signs of increased intracranial pressure
  11. Intracranial lesion
  12. History of head injury resulting in prolonged loss of consciousness
  13. Substance abuse or dependence within past six months (i.e., DSM-5 substance use disorder criteria)
  14. Chronic treatment with prescription medications that decrease cortical seizure threshold, not including psychostimulant medication if deemed to be medically safe as part of the medical review process.
  15. Active psychosis or mania
  16. Acute suicidal intent
  17. Current pregnancy
  18. Significant visual, hearing or speech impairment
  19. Dental braces
  20. Current wards of the state

Study details
    ADHD

NCT07219810

Bradley Hospital

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.